1. Home
  2. BATRK vs SUPN Comparison

BATRK vs SUPN Comparison

Compare BATRK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATRK
  • SUPN
  • Stock Information
  • Founded
  • BATRK 1991
  • SUPN 2005
  • Country
  • BATRK United States
  • SUPN United States
  • Employees
  • BATRK N/A
  • SUPN N/A
  • Industry
  • BATRK Broadcasting
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BATRK Industrials
  • SUPN Health Care
  • Exchange
  • BATRK Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • BATRK 2.5B
  • SUPN 2.0B
  • IPO Year
  • BATRK N/A
  • SUPN 2012
  • Fundamental
  • Price
  • BATRK $39.92
  • SUPN $36.38
  • Analyst Decision
  • BATRK Strong Buy
  • SUPN Hold
  • Analyst Count
  • BATRK 2
  • SUPN 1
  • Target Price
  • BATRK $53.50
  • SUPN $36.00
  • AVG Volume (30 Days)
  • BATRK 262.5K
  • SUPN 285.1K
  • Earning Date
  • BATRK 11-06-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • BATRK N/A
  • SUPN N/A
  • EPS Growth
  • BATRK N/A
  • SUPN 130.79
  • EPS
  • BATRK N/A
  • SUPN 1.07
  • Revenue
  • BATRK $678,378,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • BATRK $10.38
  • SUPN $7.82
  • Revenue Next Year
  • BATRK $5.23
  • SUPN N/A
  • P/E Ratio
  • BATRK N/A
  • SUPN $34.11
  • Revenue Growth
  • BATRK 5.31
  • SUPN 6.79
  • 52 Week Low
  • BATRK $36.74
  • SUPN $25.53
  • 52 Week High
  • BATRK $44.43
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • BATRK 45.73
  • SUPN 48.87
  • Support Level
  • BATRK $39.21
  • SUPN $35.68
  • Resistance Level
  • BATRK $40.29
  • SUPN $37.35
  • Average True Range (ATR)
  • BATRK 0.70
  • SUPN 1.01
  • MACD
  • BATRK -0.06
  • SUPN -0.18
  • Stochastic Oscillator
  • BATRK 27.76
  • SUPN 21.65

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: